BSVN
Bank7 Corp.
BSVN trails on the overall score without a compensating advantage in the available component scores.
MS
Morgan Stanley
MS has the edge over BSVN overall, supported by stronger fundamentals and stronger modeled upside.
BSVN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
BSVN's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like BSVN.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BSVN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $31.80 | -46% |
| Fair | 9.3x | $40.06 | -32% |
| Forward | 11x | $58.65 | — |
| Expensive | 12x | $50.00 | -15% |
| Current | 14x | $58.65 | — |
Historical ranges are pointers, not guarantees.
BSVN's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over BSVN in the historical PE scenario, which offers more potential upside but is not a forecast.
BSVN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BSVN, but weaker profitability. However, they disagree widely on these estimates.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over BSVN on the outlook, with more favorable profitability expectations.
BSVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.28 | +23% |
| Q3 2026 | $4.31 | -4.9% |
| Q2 2026 | $4.38 | -5.6% |
| Q1 2026 | $4.67 | -0.8% |
| Q4 2025 | $4.50 | -7% |
| Q3 2025 | $4.53 | +20% |
| Q2 2025 | $4.64 | +36% |
| Q1 2025 | $4.71 | +46% |
| Q4 2024 | $4.84 | +59% |
BSVN earned $4.31 per share over the past year, down 4.9% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BSVN on earnings, with more consistent year-over-year improvement.
BSVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.4M | -7.4% |
| Q2 2026 | $22.9M | -6.3% |
| Q1 2026 | $26.2M | +16% |
| Q4 2025 | $24.1M | -0.1% |
| Q3 2025 | $25.2M | +1.4% |
| Q2 2025 | $24.4M | +0.2% |
| Q1 2025 | $22.6M | -5.9% |
| Q4 2024 | $24.1M | -14% |
BSVN's revenue fell from its 2023 peak and has held roughly level since: $23M last quarter, down 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | +2 points |
| Q2 2026 | 48% | -12 points |
| Q1 2026 | 60% | -0.2 points |
| Q4 2025 | 59% | -2.3 points |
| Q3 2025 | 56% | -6 points |
| Q2 2025 | 60% | -2.4 points |
| Q1 2025 | 61% | -1.3 points |
| Q4 2024 | 61% | +55 points |
BSVN has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BSVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
BSVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.4M | -12% |
| Q2 2026 | $5.4M | -38% |
| Q1 2026 | $14.2M | +73% |
| Q4 2025 | $8M | -32% |
| Q3 2025 | $16.4M | +29% |
| Q2 2025 | $8.8M | +35% |
| Q1 2025 | $8.2M | -59% |
| Q4 2024 | $11.8M | -26% |
BSVN has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BSVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +35.8K shares |
| 1 year | +0.4% | +42.1K shares |
| 3 years | +4% | +366K shares |
| 5 years | +5.9% | +535K shares |
| Available history | -5% | -507K shares |
BSVN has 10M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $141,000 |
| Q2 2026 | — |
| Q1 2026 | $1.2M |
| Q4 2025 | $251,000 |
| Q3 2025 | $9,000 |
| Q2 2025 | $2,000 |
| Q1 2025 | $1M |
| Q4 2024 | $241,000 |
BSVN spent $2M buying back its own shares over the past year, up 24% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BSVN on shareholder dilution, with a more favorable share count trend.
BSVN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.0x | Net Cash |
| Q2 2026 | -3.9x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -4.2x | Net Cash |
| Q3 2025 | -4.1x | Net Cash |
| Q2 2025 | -3.7x | Net Cash |
| Q1 2025 | -4.0x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
BSVN has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BSVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.1 | Overbought |
| Stochastic | 85.8 | Overbought |
BSVN's weekly RSI is 70 (overbought) and its Stochastic is 86 (overbought).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BSVN PE vs Financial Services Sector
| Metric | BSVN | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 4.5% above |
| PE % | 96 | 63 | 33 pts above |
BSVN has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BSVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $57.3 | 2.3% above |
| 20 week MA | $54.2 | 8.3% above |
| 50 week MA | $47.6 | 23% above |
| 100 week MA | $45.0 | 30% above |
| 200 week MA | $37.2 | 58% above |
BSVN has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BSVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.0 | $13.9 | -27% |
| 2021 | $13.9 | $22.6 | +63% |
| 2022 | $22.6 | $25.7 | +14% |
| 2023 | $25.7 | $27.4 | +6.3% |
| 2024 | $27.4 | $45.8 | +67% |
| 2025 | $45.8 | $41.1 | -10% |
| 2026 YTD | $41.1 | $58.7 | +43% |
BSVN has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.